CD4 and myeloid sarcoma: CD4+ T cells from patients with HIMS induced lower levels of the co-stimulatory molecules CD80, CD86, and CD40 on DCs when compared with the levels induced by CD4+ T cells from patients with MS (Fig 4A–4C).